DXD Capital Managing Director Chris Bailey discusses his company's latest survey results on the lending sentiment in the self ...
Nukitashi, by High School DxD's Studio Passione, gained notoriety after a heavily censored version of the anime was broadcast ...
The TROPION-Breast02 trial is the first to show overall survival benefit in this patient population, indicating a potential ...
Positive topline results from the TROPION-Breast02 phase 3 trial showed DATROWAY® (datopotamab deruxtecan) demonstrated a ...
Raludotatug deruxtecan (R-DXd) received FDA breakthrough therapy designation for CDH6-expressing platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers. Phase 1 study demonstrated a ...
Trastuzumab deruxtecan (T-DXd) significantly improves IDFS over trastuzumab emtansine (T-DM1) in high-risk HER2-positive ...